• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

捕捉哺乳动物 Hippo:阐明其在癌症中的作用。

Capturing the mammalian Hippo: elucidating its role in cancer.

机构信息

Division of Cancer Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.

出版信息

Cancer Sci. 2013 Oct;104(10):1271-7. doi: 10.1111/cas.12227. Epub 2013 Aug 7.

DOI:10.1111/cas.12227
PMID:23829894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7656536/
Abstract

The Hippo pathway is an evolutionarily conserved kinase cascade involved in cell growth, apoptosis, development and migration. It is also crucial for stem cell self-renewal and the maintenance of genomic stability. In addition, this pathway has the unique capacities to sense aspects of tissue architecture, such as cell polarity and mechanical tensions imposed by the surrounding microenvironment, and to control organ size and shape. All of these properties are frequently altered in tumor cells. In this review, we summarize how dysregulation of mammalian Hippo signaling is implicated in cancer.

摘要

Hippo 通路是一条进化上保守的激酶级联反应,参与细胞生长、凋亡、发育和迁移。它对干细胞自我更新和基因组稳定性的维持也至关重要。此外,该通路具有感知组织架构方面的独特能力,如细胞极性和周围微环境施加的机械张力,并能控制器官的大小和形状。所有这些特性在肿瘤细胞中经常发生改变。在这篇综述中,我们总结了哺乳动物 Hippo 信号转导失调如何与癌症有关。

相似文献

1
Capturing the mammalian Hippo: elucidating its role in cancer.捕捉哺乳动物 Hippo:阐明其在癌症中的作用。
Cancer Sci. 2013 Oct;104(10):1271-7. doi: 10.1111/cas.12227. Epub 2013 Aug 7.
2
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal.Hippo 通路在器官大小控制、组织再生和干细胞自我更新中的作用。
Nat Cell Biol. 2011 Aug 1;13(8):877-83. doi: 10.1038/ncb2303.
3
Hippo signaling pathway and organ size control.河马信号通路与器官大小调控。
Fly (Austin). 2009 Jan-Mar;3(1):68-73. doi: 10.4161/fly.3.1.7788. Epub 2009 Jan 7.
4
The Hippo pathway and apico-basal cell polarity.Hippo 通路与顶-底细胞极性。
Biochem J. 2011 Jun 1;436(2):213-24. doi: 10.1042/BJ20110217.
5
Epithelial cell polarity, stem cells and cancer.上皮细胞极性、干细胞和癌症。
Nat Rev Cancer. 2011 Dec 15;12(1):23-38. doi: 10.1038/nrc3169.
6
Hippo pathway-dependent and -independent roles of RASSF6.RASSF6在Hippo信号通路依赖及非依赖过程中的作用
Sci Signal. 2009 Sep 29;2(90):ra59. doi: 10.1126/scisignal.2000300.
7
Ajuba LIM proteins are negative regulators of the Hippo signaling pathway.Ajuba LIM 蛋白是 Hippo 信号通路的负调控因子。
Curr Biol. 2010 Apr 13;20(7):657-62. doi: 10.1016/j.cub.2010.02.035. Epub 2010 Mar 18.
8
The hippo pathway promotes Notch signaling in regulation of cell differentiation, proliferation, and oocyte polarity.河马通路在细胞分化、增殖和卵母细胞极性的调控中促进Notch信号传导。
PLoS One. 2008 Mar 12;3(3):e1761. doi: 10.1371/journal.pone.0001761.
9
The discovery and expansion of Hippo signaling pathway in Drosophila model.Hippo信号通路在果蝇模型中的发现与拓展
Yi Chuan. 2017 Jul 20;39(7):537-545. doi: 10.16288/j.yczz.17-051.
10
Hippo signaling: a hub of growth control, tumor suppression and pluripotency maintenance.Hippo 信号通路:生长调控、肿瘤抑制和多能性维持的枢纽。
J Genet Genomics. 2011 Oct 20;38(10):471-81. doi: 10.1016/j.jgg.2011.09.009. Epub 2011 Sep 23.

引用本文的文献

1
Targeting CSC-immune cell crosstalk to overcome chemoresistance and enhance immunotherapy efficacy.靶向癌症干细胞-免疫细胞间的相互作用以克服化疗耐药性并提高免疫治疗疗效。
Front Immunol. 2025 Jul 23;16:1620807. doi: 10.3389/fimmu.2025.1620807. eCollection 2025.
2
Overexpression of SHANK2 contributes malignant outcomes as a Hippo pathway regulator in gastric cancer.作为胃癌中Hippo信号通路的调节因子,SHANK2的过表达会导致恶性结果。
Am J Cancer Res. 2025 Jan 15;15(1):363-374. doi: 10.62347/NZMO2658. eCollection 2025.
3
A Multi-Omics Prognostic Model Capturing Tumor Stemness and the Immune Microenvironment in Clear Cell Renal Cell Carcinoma.一种捕捉透明细胞肾细胞癌肿瘤干性和免疫微环境的多组学预后模型。
Biomedicines. 2024 Sep 24;12(10):2171. doi: 10.3390/biomedicines12102171.
4
Immunotherapeutic Strategies Targeting Breast Cancer Stem Cells.免疫治疗策略靶向乳腺癌干细胞。
Curr Oncol. 2024 May 29;31(6):3040-3063. doi: 10.3390/curroncol31060232.
5
Advantages of the Combinatorial Molecular Targeted Therapy of Head and Neck Cancer-A Step before Anakoinosis-Based Personalized Treatment.头颈部癌联合分子靶向治疗的优势——基于适应性个性化治疗的前一步。
Cancers (Basel). 2023 Aug 24;15(17):4247. doi: 10.3390/cancers15174247.
6
Signaling pathways in the regulation of cancer stem cells and associated targeted therapy.癌症干细胞调控中的信号通路及相关靶向治疗
MedComm (2020). 2022 Oct 5;3(4):e176. doi: 10.1002/mco2.176. eCollection 2022 Dec.
7
The role of Hippo-YAP signaling in squamous cell carcinomas.Hippo-YAP 信号通路在鳞状细胞癌中的作用。
Cancer Sci. 2021 Jan;112(1):51-60. doi: 10.1111/cas.14725. Epub 2020 Dec 9.
8
Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness.针对癌症干性相关信号通路的治疗靶向作用
Front Oncol. 2020 Aug 26;10:1533. doi: 10.3389/fonc.2020.01533. eCollection 2020.
9
Association of Mps one binder kinase activator 1 (MOB1) expression with poor disease-free survival in individuals with non-small cell lung cancer.Mps one binder kinase activator 1(MOB1)表达与非小细胞肺癌患者无病生存不良相关。
Thorac Cancer. 2020 Oct;11(10):2830-2839. doi: 10.1111/1759-7714.13608. Epub 2020 Aug 25.
10
The Effects of YAP and Its Related Mechanisms in Central Nervous System Diseases.YAP在中枢神经系统疾病中的作用及其相关机制
Front Neurosci. 2020 Jun 26;14:595. doi: 10.3389/fnins.2020.00595. eCollection 2020.

本文引用的文献

1
The Hippo pathway and human cancer.Hippo 通路与人类癌症。
Nat Rev Cancer. 2013 Apr;13(4):246-57. doi: 10.1038/nrc3458. Epub 2013 Mar 7.
2
The Hippo pathway: regulators and regulations.Hippo 通路:调控因子及其调控机制。
Genes Dev. 2013 Feb 15;27(4):355-71. doi: 10.1101/gad.210773.112.
3
β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis.β-连环蛋白驱动的癌症需要 YAP1 转录复合物来维持生存和促进肿瘤发生。
Cell. 2012 Dec 21;151(7):1457-73. doi: 10.1016/j.cell.2012.11.026. Epub 2012 Dec 13.
4
Restriction of intestinal stem cell expansion and the regenerative response by YAP.YAP 限制肠道干细胞的扩增和再生反应。
Nature. 2013 Jan 3;493(7430):106-10. doi: 10.1038/nature11693. Epub 2012 Nov 25.
5
Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice.Mob1a/1b 双突变小鼠的癌症易感性和胚胎致死性。
J Clin Invest. 2012 Dec;122(12):4505-18. doi: 10.1172/JCI63735. Epub 2012 Nov 12.
6
Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.G 蛋白偶联受体信号对 Hippo-YAP 通路的调控。
Cell. 2012 Aug 17;150(4):780-91. doi: 10.1016/j.cell.2012.06.037. Epub 2012 Aug 2.
7
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP.遗传和药理学破坏 TEAD-YAP 复合物可抑制 YAP 的致癌活性。
Genes Dev. 2012 Jun 15;26(12):1300-5. doi: 10.1101/gad.192856.112. Epub 2012 Jun 7.
8
The Mst1 and Mst2 kinases control activation of rho family GTPases and thymic egress of mature thymocytes.Mst1 和 Mst2 激酶控制 rho 家族 GTPases 的激活和成熟胸腺细胞的胸腺输出。
J Exp Med. 2012 Apr 9;209(4):741-59. doi: 10.1084/jem.20111692. Epub 2012 Mar 12.
9
The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells.Hippo 信号转导通路的效应物 TAZ 赋予乳腺癌细胞癌症干细胞相关特性。
Cell. 2011 Nov 11;147(4):759-72. doi: 10.1016/j.cell.2011.09.048.
10
Hippo pathway regulation by cell morphology and stress fibers.Hippo 通路受细胞形态和应激纤维的调节。
Development. 2011 Sep;138(18):3907-14. doi: 10.1242/dev.070987. Epub 2011 Aug 10.